Preservation and stability of cell therapy products: recommendations from an expert workshop
journal contributionposted on 2017-10-23, 09:07 authored by Glyn Stacey, Che J. Connon, Karen CoopmanKaren Coopman, Alan J. Dickson, Barry Fuller, Charles J. Hunt, P. Kemp, Julie Kerby, Jennifer Man, Paul Matejtschuk, Harry Moore, John Morris, Richard O.C. Oreffo, Nigel K.H. Slater, S. Ward, Claire Wiggins, Heiko Zimmermann
If the field of regenerative medicine is to deliver therapies, rapid expansion and delivery over considerable distances to large numbers of patients is needed. This will demand efficient stabilization and shipment of cell products. However, cryopreservation science is poorly understood by life-scientists in general and in recent decades only limited progress has been made in the technology of preservation and storage of cells. Rapid translation of new developments to a broader range of cell types will be vital, as will assuring a deeper knowledge of the fundamental cell biology relating to successful preservation and recovery of cell cultures. This report presents expert consensus on these and other issues which need to be addressed for more efficient delivery of cell therapies.
- Aeronautical, Automotive, Chemical and Materials Engineering
- Chemical Engineering
Published inRegenerative Medicine
CitationSTACEY, G. ...et al., 2017. Preservation and stability of cell therapy products: recommendations from an expert workshop. Regenerative Medicine, 12(5), pp. 553–564.
Publisher© Future Medicine
- AM (Accepted Manuscript)
Publisher statementThis work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/
NotesThis paper was published in the journal Regenerative Medicine and the definitive published version is available at https://doi.org/10.2217/rme-2017-0073.